Blog

28 Oct 2022

Here are Mass. institutions that got the most in NIH grants in 2022

28 Oct 2022

Blue Cross CEO Andrew Dreyfus reflects on 12-year tenure

28 Oct 2022

Viewpoint: Mass. needs investment to maintain life sciences dominance

27 Oct 2022

Fidelity study: Interest in digital assets rising worldwide despite volatility

27 Oct 2022

After pause, Beverly Hospital set to finalize closure of North Shore Birth Cente...

27 Oct 2022

Braintree manufacturer Altra to be acquired for $5 billion

27 Oct 2022

USA Curling is in an uproar, and a Mass. club is caught in the middle

27 Oct 2022

Penn Medicine and Boston-area biopharm firm to pursue potential solid tumor CAR...

27 Oct 2022

Five life sciences trends to watch for in 2023

27 Oct 2022

A biopharma firm with a unique public-private model opens in Watertown

27 Oct 2022

Earlier this year, Cybereason was gearing up for an IPO. Now, it’s laying...

27 Oct 2022

Letter to the editor: Passing Question 1 would be an ‘economic disaster...